Mechanisms of monocyte recruitment in vascular repair after injury

被引:58
作者
Schober, A
Weber, C
机构
[1] Univ Klinikum Aachen, Dept Mol Cardiolvasc Res, D-52074 Aachen, Germany
[2] Klinikum Univ Munchen, Abt Kardiol, Med Poliklin, Div Cardiol, D-80336 Munich, Germany
关键词
D O I
10.1089/ars.2005.7.1249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The inflammatory response to acute vessel wall injury has been increasingly recognized to play a decisive role in neointima formation. In particular, the exuberant infiltration with monocytes aggravates neointimal growth and can thereby promote restenosis. The adhesion of circulating monocytes to the site of mechanical injury represents the key event in monocyte recruitment, and this review highlights recent insights into the molecular mechanisms of monocyte adhesion throughout the course of neointimal growth. An acute and a chronic phase of monocyte recruitment after vascular injury can be discerned. The adhesion of platelets to the denuded subendothelial matrix is the hallmark of the acute phase providing an adhesive substrate for monocytes, whereas chronic monocyte recruitment is regulated by the interaction with neointimal smooth muscle cells and recovering endothelial cells. Clearly, the mechanisms of monocyte rolling and adhesion differ considerably between these diverse substrates. This review is particularly focused on the contribution of chemokines and adhesion molecules to monocyte recruitment to injured vessels according to the different stages of neointimal growth, and on closely related functions of the chemokine-like molecule macrophage migration inhibitory factor. Understanding the complex molecular interactions of the injured vessel wall with circulating monocytes may enable therapeutic targeting to prevent the development of restenosis.
引用
收藏
页码:1249 / 1257
页数:9
相关论文
共 93 条
[1]   Enhancement of oxidised low-density lipoprotein uptake by macrophages in response to macrophage migration inhibitory factor [J].
Atsumi, T ;
Nishihira, J ;
Makita, Z ;
Koike, T .
CYTOKINE, 2000, 12 (10) :1553-1556
[2]   α4β1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) mice [J].
Barringhaus, KG ;
Phillips, JW ;
Thatte, JS ;
Sanders, JM ;
Czarnik, AC ;
Bennett, DK ;
Ley, KF ;
Sarembock, IJ .
JOURNAL OF VASCULAR RESEARCH, 2004, 41 (03) :252-260
[3]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[4]   An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction [J].
Bernhagen, J ;
Bacher, M ;
Calandra, T ;
Metz, CN ;
Doty, SB ;
Donnelly, T ;
Bucala, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :277-282
[5]   Medical progress: Advances in coronary angioplasty [J].
Bittl, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (17) :1290-1302
[6]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[7]   Activation of nuclear factor-κB significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model [J].
Breuss, JM ;
Cejna, M ;
Bergmeister, H ;
Kadl, A ;
Baumgartl, G ;
Steurer, S ;
Xu, Z ;
Koshelnick, Y ;
Lipp, J ;
De Martin, R ;
Losert, U ;
Lammer, J ;
Binder, BR .
CIRCULATION, 2002, 105 (05) :633-638
[8]   Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis [J].
Burger-Kentischer, A ;
Goebel, H ;
Seder, R ;
Fraedrich, G ;
Schaefer, HE ;
Dimmeler, S ;
Kleemann, R ;
Bernhagen, J ;
Ihling, C .
CIRCULATION, 2002, 105 (13) :1561-1566
[9]   MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902
[10]   MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].
CALANDRA, T ;
BERNHAGEN, J ;
METZ, CN ;
SPIEGEL, LA ;
BACHER, M ;
DONNELLY, T ;
CERAMI, A ;
BUCALA, R .
NATURE, 1995, 377 (6544) :68-71